StonvexLoading…
StonvexStonvexStonvexCore line items from VMC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.76B | $7.94B | $6.03B | $3.74B |
Operating Income | $265.40M | $1.62B | $1.24B | $697.40M |
Net Income | $165.50M | $1.08B | $824.70M | $449.80M |
EPS (Diluted) | $1.26 | $8.11 | $6.21 | $3.38 |
Total Assets | $16.67B | $16.70B | $16.98B | $16.97B |
Total Liabilities | $8.20B | $8.15B | $8.22B | $8.54B |
Cash & Equivalents | $140.20M | $183.30M | $191.30M | $347.40M |
Free Cash Flow OCF − CapEx | $64.60M | $1.14B | $777.10M | $322.30M |
Shares Outstanding | 130.30M | 130.60M | 132.00M | 132.00M |